Windtree Therapeutics Inc...

NASDAQ: WINT · Real-Time Price · USD
0.51
-0.01 (-1.28%)
At close: Aug 15, 2025, 3:02 PM

Windtree Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-1.79M -20.29M -39.21M -67.64M
Depreciation & Amortization
84K 82K 533K 192K
Stock-Based Compensation
455K 1.28M 3.09M 7.24M
Other Working Capital
301K 1.46M -1.33M 410K
Other Non-Cash Items
-15.31M 3.48M 19.28M 46.59M
Deferred Income Tax
-210K n/a -1.37M -9.99M
Change in Working Capital
1.37M 2.02M -1.78M -58K
Operating Cash Flow
-15.4M -13.44M -19.45M -23.66M
Capital Expenditures
-12K -15K -13K -279K
Cash Acquisitions
n/a n/a 210K n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a 210.00 n/a
Investing Cash Flow
-12K -15K 197K -279K
Debt Repayment
1.26M -797K -1.17M n/a
Common Stock Repurchased
-1.88M n/a n/a n/a
Dividend Paid
-657K n/a n/a n/a
Other Financial Acitivies
8.52M 843K n/a 29.36M
Financial Cash Flow
12.73M 11.6M 3.08M 29.36M
Net Cash Flow
-2.68M -1.86M -16.18M 5.42M
Free Cash Flow
-15.41M -13.45M -19.46M -23.94M